门静脉高压症食管旁静脉的CT检查解剖特征及临床意义

来源 :中华消化外科杂志 | 被引量 : 0次 | 上传用户:tiger0092009
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨门静脉高压症患者食管旁静脉的CT检查解剖特征及临床意义。方法:采用回顾性描述性研究方法。收集2018年1月至2021年6月宁夏回族自治区人民医院收治的173例门静脉高压症患者的临床资料;男124例,女49例;中位年龄为47岁,年龄范围为22~71岁。观察指标:(1)术前CT检查情况。(2)手术情况。(3)随访情况。采用门诊随访,术后6个月内,每3个月随访1次,之后每6个月随访1次,了解患者手术疗效。随访时间截至2021年6月。偏态分布的计数资料以n M(范围)表示。计数资料以绝对数表示。n 结果:(1)术前CT检查情况:门静脉高压症患者食管旁静脉CT检查显示率为52.60%(91/173)。173例患者中,82例未显示食管旁静脉,91例显示存在食管旁静脉。91例显示存在食管旁静脉的患者中,食管旁静脉曲张46例,粗食管旁静脉24例,细食管旁静脉21例。91例显示存在食管旁静脉的患者中,无食管静脉曲张(EV)8例,合并EV 83例。83例合并EV患者中,食管旁静脉单独汇入奇静脉或半奇静脉44例,膈肌上形成食管旁静脉曲张并与EV 汇合后共同汇入奇静脉39例。(2)手术情况:173例患者顺利完成手术,其中单纯脾切除术8例,脾切除联合改良彻底断流术86例,脾切除联合重建自发性胃肾分流断流术35例,脾切除联合保留食管旁静脉断流术41例,脾切除联合食管旁静脉环缩术3例。173例患者无手术死亡,67例发生并发症(3例单纯脾切除术、29例脾切除联合改良彻底断流术、11例脾切除联合重建自发性胃肾分流断流术、23例脾切除联合保留食管旁静脉断流术、1例脾切除联合食管旁静脉环缩术)。(3)随访情况:173例患者中,159例获得随访,随访时间为6~42个月,中位随访时间为28个月。7例单纯脾切除术获得随访患者中,无EV 6例,EV复发1例。79例脾切除联合改良彻底断流术获得随访患者中,无EV 5例,EV轻、中度残留67例,EV重度残留5例,EV复发1例,EV复发破裂出血1例。34例脾切除联合重建自发性胃肾分流断流术获得随访患者中,无EV 7例,EV轻、中度残留27例。36例脾切除联合保留食管旁静脉断流术患者中,无EV 4例,EV轻、中度残留21例,EV重度残留5例,EV 复发4例,EV复发破裂出血2例。3例脾切除联合食管旁静脉环缩术获得随访患者中,EV轻、中度残留2例,EV重度残留1例。结论:门静脉高压症患者食管旁静脉CT检查显示率>50%,血管内径及走行方式不同;食管旁静脉的CT检查解剖特征可以为制订手术方式提供参考。“,”Objective:To investigate the computed tomography (CT) examination anato-mical features and clinical significance of paraesophageal vein (PEV) in portal hypertension.Methods:The retrospective and descriptive study was conducted. The clinical data of 173 patients with portal hypertension who were admitted to the People\'s Hospital of Ningxia Hui Autonomous Region from January 2018 to June 2021 were collected. There were 124 males and 49 females, aged from 22 to 71 years, with a median age of 47 years. Observation indicators: (1) preoperative CT examinations; (2) surgical situations; (3) follow-up. Follow-up was conducted using outpatient examination to detect surgical effects once every 3 months within postoperative 6 months and once every 6 months after postoperative 6 months. The follow-up was up to June 2021. Measurement data with skewed distribution were represented as n M(range) and count data were described as absolute numbers.n Results:(1) Preoperative CT examinations. The CT detection rate of PEV in the 173 portal hyper-tension patients was 52.60%(91/173). Of 173 patients, 82 cases were negative with PEV and 91 cases were positive with PEV. Of the 91 patients who were positive with PEV, there were 46 cases with paraesophageal varices, 24 cases with thick PEV, 21 cases with thin PEV, 8 cases without esophageal varices and 83 cases accompanied with esophageal varices. Of the 83 patients who were accom-panied with esophageal varices, there were 44 cases with PEV converged alone with azygos vein or semiazygos vein, 39 cases with paraesophageal varices formed above the diaphragm confluent with esophageal varices into azygos vein. (2) Surgical situations. All the 173 patients underwent surgery successfully, including 8 cases undergoing splenectomy, 86 cases undergoing splenectomy combined with modified complete devascularization, 35 cases undergoing splenectomy combined with spontaneous gastrorenal shunt reconstructing devascularization, 41 cases undergoing splenectomy combined with PEV preserving devascularization and 3 cases undergoing splenectomy combined with PEV ring constriction. None of 173 patients had surgical relative death, 67 cases had complica-tions, including 3 cases undergoing splenectomy, 29 cases undergoing splenectomy combined with modified complete devascularization, 11 cases undergoing splenectomy combined with spontaneous gastrorenal shunt reconstructing devascularization, 23 cases undergoing splenectomy combined with PEV preserving devascularization and 1 case undergoing splenectomy combined with PEV ring constriction underwent complications. (3) Follow-up. Of the 173 patients, 159 cases were followed up for 6 to 42 months, with a median follow-up time of 28 months. In the 7 cases undergoing splenectomy who were followed up, there were 6 cases without esophageal varices and 1 case with recurrence of esophageal varices. In the 79 cases undergoing splenectomy combined with modified complete devascularization who were followed up, there were 5 cases without esophageal varices, 67 cases with mild to moderate residual of esophageal varices, 5 cases with severe residual of esophageal varices, 1 case with recurrence of esophageal varices and 1 case with recurrence of esophageal varices hemorrhage. In the 34 cases undergoing splenectomy combined with sponta-neous gastrorenal shunt reconstructing devascularization who were followed up, there were 7 cases without esophageal varices and 27 cases with mild to moderate residual of esophageal varices. In the 36 cases undergoing splenectomy combined with PEV preserving devascularization who were followed up, there were 4 cases without esophageal varices, 21 cases with mild to moderate residual of esophageal varices, 5 cases with severe residual of esophageal varices, 4 cases with recurrence of esophageal varices and 2 cases with recurrence of esophageal varices hemorrhage. In the 3 cases undergoing splenectomy combined with PEV ring constriction who were followed up, there were 2 cases with mild to moderate residual of esophageal varices, 1 case with severe residual of esophageal varices.Conclusions:The CT detection rate of PEV in portal hypertension patients is >50% and the internal diameter and distribution of blood vessels are different in patients. CT examination anatomical features of PEV can be used to guide the formula-tion of surgical methods.
其他文献
目的:制订《肥胖代谢外科个案管理中国专家共识(2022版)》,以推动我国肥胖代谢外科个案管理规范化发展。方法:在全面回顾个案管理来源、国外个案管理模式、国际肥胖代谢外科专科护士考核内容、肥胖代谢外科围手术期管理指南与共识基础上,对7位具有>5年肥胖代谢外科个案管理经验的专家进行访谈,形成《肥胖代谢外科个案管理中国专家共识(2022版)》初稿,并完成第1轮专家论证。根据专家意见修改后,邀请37位相关领域专家,完成第2轮专家论证,经修订后形成《肥胖代谢外科个案管理中国专家共识(2022版)》。结果:《肥胖代谢
转化治疗已成为临界可切除或不可切除肝癌治疗的核心,为更多晚期肝癌患者提供可切除机会。根据临床指南关于肝癌一线治疗方案推荐,笔者总结并分析1例初始临界可切除中晚期肝癌患者行阿替利珠单克隆抗体联合贝伐珠单克隆抗体(T+A方案)转化治疗后,成功行肝段切除术,且术后9个月随访未见肿瘤复发。该例患者术后病理学检查为肝细胞-胆管细胞混合型肝癌。这提示T+A方案在混合型肝癌转化治疗中具有重要价值。“,”Conversion therapy has become the core in the treatment of
目的 探讨计算机断层扫描冠状动脉造影(CTCA)测量的血管狭窄程度和冠状动脉钙化评分(CACS),是否能预测接受非心脏手术患者的术后心血管事件.?方法 2013年6月至2018年6月在空军特色医学中心共有117例患者进行非心脏手术前接受CTCA.用CTCA测量血管狭窄程度和CACS,并根据修订的心脏风险指数(RCRI)评价临床危险因素.根据0,1,2或≥3个临床危险因素将患者分为0,1,2或≥3分RCRI组别.血管狭窄程度和CACS评分预测术后心血管事件.?结果 18例患者发生术后30 d心血管事件.有术
目的:探讨阿伐曲泊帕联合重组人血小板生成素(rhTPO)和阿伐曲泊帕单药治疗慢性肝病相关重度血小板减少症(TCP)的临床疗效。方法:采用回顾性队列研究方法。收集2020年5月至2021年10月中国科学技术大学附属第一医院收治的56例慢性肝病相关重度TCP患者的临床资料;男36例,女20例;中位年龄54岁,年龄范围为33~74岁。56例患者中,21例采用阿伐曲泊帕联合rhTPO方案设为联合治疗组,35例采用阿伐曲泊帕单药方案设为单药治疗组。观察指标:(1)用药后血小板(PLT)变化情况。(2)药物不良反应情
心脏大血管外科自上世纪50年代问世以来,经历了70多年的发展过程,不断突破创新,目前已经能够治疗所有心脏和主动脉血管的器质性疾病,挽救了数以百万计患者的生命.迄今为止,国内外主流的单位对于绝大多数心血管手术还是采用传统的经胸骨正中切口的方式来进行.该入路显露充分,方便操作,能够处理所有术中意外事件,有着最大的安全保障,所以时至今日,仍然牢牢占据着最主流的位置.
期刊
目的 探讨血清中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平对高血压病患者发生颈动脉粥样硬化的诊断价值及与颈动脉斑块状态的关系.?方法 选取2017年10月9日至2018年8月17日在江苏盛泽医院体检的高血压患者112例,根据有无颈动脉粥样硬化分为观察组62例和对照组50例.收集患者一般资料,检测患者NGAL水平以及超声检查颈动脉.使用多因素二元Logistic回归分析高血压患者伴发颈动脉粥样硬化的影响因素.利用ROC曲线评估NGAL对高血压患者伴发颈动脉斑块形成的预测能力.?结果 观察组相较于对照组吸
目的 比较大动物心脏手术实验中氯胺酮肌注和异氟烷吸入全身麻醉诱导的优劣,探索更适合大动物心脏手术的围术期麻醉管理策略,以提高实验质量、促进临床转化.?方法 选取体外循环下主动脉瓣置换术的小尾寒羊36只,随机均分为两组.分别给予肌肉注射8 mg/kg氯胺酮诱导和2%异氟烷面罩吸入诱导,合理追加剂量直至气管插管成功.术中麻醉维持均采用一致的静吸复合麻醉方案.收集插管期间的心率、血压指标,记录麻醉诱导时间、手术时长、体外循环时长、体外循环前及结束后的血气指标、麻醉药物总用量和动物死亡数量等.?结果 相较于氯胺酮
冠状动脉疾病已成为全球发病率和死亡率最高的疾病之一 [1].虽然基于指南的药物治疗仍是冠状动脉疾病治疗的基础,但对于急性冠状动脉综合征、左主干病变和多支血管病变等阻塞性冠状动脉病变的患者来说,经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)或冠状动脉旁路搭桥术(coronary artery bypass graft, CABG)能带来更多的益处 [2].根据治疗后是否还存在残余的血管病变, PCI或CABG术可被分为实现了完全血运重建(complet
期刊
上世纪90 年代,Angelini 等[1] 首次报道了微创直接冠状动脉搭桥(minimally invasive direct coronaryartery bypass, MIDCAB)和经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)相结合的“杂交”冠状动脉血运重建(hybrid coronary revascularization,HCR),为冠心病的治疗提供了一种新的方式.随着PCI 进入药物洗脱支架(drug eluting stent,
期刊
2021年全球新型冠状病毒疫情进入常态化,继续对临床研究造成巨大影响.尽管如此,国内外神经介入领域仍维持高速发展,多项重磅研究和治疗进展陆续公布和发表.本文回顾了2021年神经介入行业内最具影响力的研究和进展,内容涵盖神经介入相关诊断、治疗、新器械、机器人技术等领域.
期刊